Compare TeraWulf Inc (WULF) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TeraWulf Inc vs State Street SPDR S&P Biotech ETF — how do they compare? TeraWulf Inc trades at $19.95 (market cap $9.35B), while State Street SPDR S&P Biotech ETF trades at $154.5. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals.
| WULF | XBI | |
|---|---|---|
Market Cap | $9.35B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $28.98 | $164.28 |
52-Week Low | $4.76 | $85.16 |
Enterprise Value | $12.03B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
